Figure 3

Mean time since last intravitreal aflibercept (IVT-AFL) injection at 12 and at 24 months after IVT-AFL initiation analysed as continuous (a) and as categorical (b) variable based on observed cases.

Mean time since last intravitreal aflibercept (IVT-AFL) injection at 12 and at 24 months after IVT-AFL initiation analysed as continuous (a) and as categorical (b) variable based on observed cases.